PT Hetzer Medical Indonesia Tbk (IDX:MEDS)

IDX:MEDS Statistics

Total Valuation

IDX:MEDS has a market cap or net worth of IDR 129.69 billion. The enterprise value is 134.00 billion.

Market Cap	129.69B
Enterprise Value	134.00B

Important Dates

The next estimated earnings date is Thursday, October 23, 2025.

Earnings Date	Oct 23, 2025
Ex-Dividend Date	n/a

Share Statistics

IDX:MEDS has 1.56 billion shares outstanding.

Current Share Class	1.56B
Shares Outstanding	1.56B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	70.91%
Owned by Institutions (%)	n/a
Float	454.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	38.51
PB Ratio	2.37
P/TBV Ratio	2.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.29
EV / Sales	39.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-510.15

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.08.

Current Ratio	2.25
Quick Ratio	0.63
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-17.33
Interest Coverage	-20.09

Financial Efficiency

Return on equity (ROE) is -15.75% and return on invested capital (ROIC) is -9.13%.

Return on Equity (ROE)	-15.75%
Return on Assets (ROA)	-8.64%
Return on Invested Capital (ROIC)	-9.13%
Return on Capital Employed (ROCE)	-16.73%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	18
Asset Turnover	0.05
Inventory Turnover	0.42

Taxes

In the past 12 months, IDX:MEDS has paid 263.36 million in taxes.

Income Tax	263.36M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +64.00% in the last 52 weeks. The beta is 1.06, so IDX:MEDS's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	+64.00%
50-Day Moving Average	61.08
200-Day Moving Average	52.77
Relative Strength Index (RSI)	72.31
Average Volume (20 Days)	53,148,985

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IDX:MEDS had revenue of IDR 3.37 billion and -9.38 billion in losses. Loss per share was -6.00.

Revenue	3.37B
Gross Profit	-1.06B
Operating Income	-9.57B
Pretax Income	-9.11B
Net Income	-9.38B
EBITDA	-5.55B
EBIT	-9.57B
Loss Per Share	-6.00

Balance Sheet

The company has 243.36 million in cash and 4.55 billion in debt, giving a net cash position of -4.31 billion or -2.76 per share.

Cash & Cash Equivalents	243.36M
Total Debt	4.55B
Net Cash	-4.31B
Net Cash Per Share	-2.76
Equity (Book Value)	54.83B
Book Value Per Share	35.09
Working Capital	9.31B

Cash Flow

In the last 12 months, operating cash flow was -99.18 million and capital expenditures -163.48 million, giving a free cash flow of -262.66 million.

Operating Cash Flow	-99.18M
Capital Expenditures	-163.48M
Free Cash Flow	-262.66M
FCF Per Share	-0.17

Margins

Gross margin is -31.56%, with operating and profit margins of -284.06% and -278.43%.

Gross Margin	-31.56%
Operating Margin	-284.06%
Pretax Margin	-270.61%
Profit Margin	-278.43%
EBITDA Margin	-164.78%
EBIT Margin	-284.06%
FCF Margin	n/a

Dividends & Yields

IDX:MEDS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-7.23%
FCF Yield	-0.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IDX:MEDS has an Altman Z-Score of 4.4 and a Piotroski F-Score of 2.

Altman Z-Score	4.4
Piotroski F-Score	2